Strategic management consultancy with a patient-centered focus spanning small and large healthcare organizations. Sample client work includes:
• For a small start-up, worked hand in hand with the C-Suite to serve as a strategic thought partner and overall project manager to help drive strategic planning, define the overarching brand vision, positioning, goals, and objectives. Worked cross-functionally and with senior leadership to develop plans to reach key stakeholders, developed and managed the strategic planning process from start to finish, including establishing clear milestones, KPIs and success metrics, and ensuring organizational alignment along the way.
• For a mid-size oncology company, served as a trusted advisor for a member of the market access leadership team, consulting on brand strategy for future products, participating on cross-functional program strategy teams, collaborating on senior leadership presentation decks, and driving relevant workstreams.

Responsible for global commercial strategy to optimize the launch and commercial success of innovative gene therapy approach for patients with beta thalassemia. Member of inaugural commercial team in preparation for the organizational transition from clinical to commercial stage.
● • Led commercial team in development of the global commercial strategy, including market
Laura B. Weinstein
● development, stakeholder networks, disease platform and brand platform.
• Collaborated seamlessly with corresponding development lead on overall asset strategy and execution to drive well informed cross-matrix decisions and plans.
• Developed and executed clear, concise, and actionable global strategic and tactical plans.
• Managed global brand launch forecasts and long-range financial plans.
• Ensured alignment of brand strategy and execution across functions and geographies to create and maintain a successful, global team orientation.

Established and built global market access marketing excellence within oncology-focused molecular diagnostics and precision medicine cancer genomics company.
● • Commercial lead for multi-faceted, cross-functional due diligence efforts for billion-dollar deal with Roche.
• Co-led ongoing ex-US commercialization alliance with Roche, including market planning, global launch strategy, and European operational strategy.
• Global access lead and integral member of launch core team and strategic alliance team for companion diagnostic (CDx) commercialization collaboration with Clovis Oncology.
• Developed and launched annual strategic and tactical market access plans, enabling U.S. field-based payer relations team to build momentum among payer thought leaders.
• Delivered market access value proposition, including health economics evidence generation strategy and core value messages and materials to bolster U.S. payer relations efforts.
• Collaborated with government affairs, advocacy

Recruited to "relaunch" core radiopharmaceutical portfolio within highly competitive hospital-based imaging agent market. Rewarded with additional responsibilities within first six months to design and implement global strategies, marketing campaigns, and initiatives for a hospital-based diagnostic ultrasound contrast agent.
● • Delivered growth due to new promotional efforts and new pricing models within the U.S. hospital-based radiopharmaceutical business after multiple years of declining revenue.
• Developed and launched strategic messaging, materials, and programs following a four-month ultrasound contrast agent supply shortage that enabled the brand to return to pre-outage market penetration and market share within three months in a competitive market.
• Created long-term and annual strategic and tactical plans that maximized life cycle opportunities and successfully delivered growth objectives across the imaging agent portfolio.
• Managed annual and five-year product forecast

Associate Director, Cerezyme Global Marketing & Strategic Development Senior Product Manager, Cerezyme Global Marketing
● Promoted to deliver long-range strategic plans and overarching global brand strategies for the PGH business. Within matrix environment, collaborated closely with team counterparts in international affiliates to implement global strategies, portfolio pricing, marketing campaigns, and market access initiatives.
● • Created annual and long-range global brand plans that strengthened brand positioning, messaging, and competitive strategy.
Laura B. Weinstein
● • Managed quarterly and long-range forecast and budget for the Asia Pacific region with Business Unit finance and global affiliates.
• Led cross-functional, global team to pioneer and launch comprehensive patient support program that strengthened brand equity.
• Integral member of core team for global innovative pricing, reimbursement, and franchise management strategy for Gaucher franchise

• P&L responsibility for four unique and highly specialized product lines of immunologic and genetic neurological testing services worth approximately one-third of the company's overall revenue.
• Delivered double-digit annual revenue growth in the product lines each year due to targeted promotional campaigns.
• Successfully launched two new molecular diagnostic assays in the high-profile epilepsy franchise, which contributed to significant revenue growth within the franchise.

• Analyzed best practice approaches and strategic solutions to improve the market position of a major pharmaceutical company.
• Developed recommendations that drove key decisions around a health system's need for expansion of clinical research and training based on current activity, operational plans for growth, and strategic initiatives.
• Restructured the financial relationships between a major hospital system and its affiliated clinical practices, including pricing and reimbursement of services.

• Devised pre- and post-launch strategic and tactical marketing plans, including product positioning, pricing, promotional efforts, and forecasts to stimulate sustained business growth.
• Assessed business development opportunities for both individual products and entire product lines through financial valuation models and projected cash flows.

• Streamlined, prioritized, and provided strategic market analyses and commercial input for early-stage compounds. Analyzed current market trends and opportunities, including unmet clinical needs, for several therapeutic indications.

• Member of a research team within the Section of General Internal Medicine Research Unit measuring HIV medication adherence in a randomized controlled trial. Validated study hypotheses through designing and administering quantitative research interviews to targeted patient groups. Synthesized research data and analyzed statistical reports for study conclusions.